Treatment costs · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
The review found no eligible studies for this question.
1 finding from 1 review
Treatment costs: no trials reported this outcome (extrapolated by the review authors). Additional costs were associated with the long-implant + augmentation group (extra surgery, biomaterial, barrier, hospitalisation…
0 studies
No studies found
Patient preference · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
1 finding from 1 review
Complications (at treated sites) · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants may leads to higher complications (at treated sites) compared with short implants (5 to 8.5 mm) without sinus augmentation (low certainty).
1 finding from 1 review
Augmentation procedure failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
1 finding from 1 review
Implant failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants showed no clear difference in implant failure compared with short implants (5 to 8.5 mm) without sinus augmentation (moderate certainty).
1 finding from 1 review
Prosthesis failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants showed no clear difference in prosthesis failure compared with short implants (5 to 8.5 mm) without sinus augmentation (moderate certainty).
1 finding from 1 review
Harmful alcohol use · alcohol use disorder
2 findings from 1 review
Retention [ · alcohol use disorder
Pharmacologic intervention along with psychosocial intervention showed no clear difference in retention compared with psychosocial intervention alone (moderate certainty).
1 finding from 1 review
MACE · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in MACE compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
Death · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in death compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
All major occlusive vascular events · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in all major occlusive vascular events compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
Intracerebral haemorrhage (ICH) · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in intracerebral haemorrhage (ICH) compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
Functional outcomes · survivors of stroke due to intracerebral haemorrhage
Summary of findings table ‐ Starting long‐term oral antiplatelet… showed no clear difference in fnctional status (mRS 0‐2) compared with avoiding antithrombotic therapy (moderate certainty).
1 finding from 1 review
Functional ability · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in functional status (mRS 0‐2) compared with avoiding anticoagulation (low certainty).
1 finding from 1 review
MACE · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… probably leads to lower MACE (MACE) compared with avoiding anticoagulation (moderate certainty).
1 finding from 1 review
Death · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in death compared with avoiding anticoagulation (moderate certainty).
1 finding from 1 review
All major occlusive vascular events · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… probably leads to lower all major occlusive vascular events compared with avoiding anticoagulation (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · survivors of stroke due to intracerebral haemorrhage with atrial fibrillation
Summary of findings table ‐ Starting long‐term therapeutic dose oral… showed no clear difference in intracranial haemorrhage compared with avoiding anticoagulation (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · term and preterm infants resuscitated at birth, using positive pressure ventilation
Nasal interfaces (single nasal prong, binasal prongs (long or… showed no clear difference in death before discharge compared with face mask (low certainty).
1 finding from 1 review
Intubation and mechanical ventilation in the DR · term and preterm infants resuscitated at birth, using positive pressure ventilation
It is very uncertain whether nasal interfaces (single nasal prong, binasal prongs (long or… changes intubation and mechanical ventilation in the DR compared with face mask (very low certainty).
1 finding from 1 review